These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29448001)

  • 1. Induced pluripotent stem cells (iPSC)-derived retinal cells in disease modeling and regenerative medicine.
    Rathod R; Surendran H; Battu R; Desai J; Pal R
    J Chem Neuroanat; 2019 Jan; 95():81-88. PubMed ID: 29448001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal Pigment Epithelium Regeneration by Induced Pluripotent Stem Cells; Therapeutic and Modelling Approaches on Retinal Degenerative Diseases.
    Setayeshi S; Rasoulinejad SA
    Curr Stem Cell Res Ther; 2021; 16(6):710-717. PubMed ID: 33511959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement.
    Di Foggia V; Makwana P; Ali RR; Sowden JC
    J Ocul Pharmacol Ther; 2016 Jun; 32(5):240-52. PubMed ID: 27027805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoid technology for retinal repair.
    Llonch S; Carido M; Ader M
    Dev Biol; 2018 Jan; 433(2):132-143. PubMed ID: 29291970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders.
    Benati D; Leung A; Perdigao P; Toulis V; van der Spuy J; Recchia A
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
    Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y
    J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases.
    Wiley LA; Burnight ER; Songstad AE; Drack AV; Mullins RF; Stone EM; Tucker BA
    Prog Retin Eye Res; 2015 Jan; 44():15-35. PubMed ID: 25448922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects.
    Singh R; Cuzzani O; Binette F; Sternberg H; West MD; Nasonkin IO
    Stem Cell Rev Rep; 2018 Aug; 14(4):463-483. PubMed ID: 29675776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pluripotent stem cells: A toolbox to understand and treat retinal degeneration.
    Morizur L; Herardot E; Monville C; Ben M'Barek K
    Mol Cell Neurosci; 2020 Sep; 107():103523. PubMed ID: 32634576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous stem cell therapy for inherited and acquired retinal disease.
    Apatoff MBL; Sengillo JD; White EC; Bakhoum MF; Bassuk AG; Mahajan VB; Tsang SH
    Regen Med; 2018 Jan; 13(1):89-96. PubMed ID: 29360008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent technological updates and clinical applications of induced pluripotent stem cells.
    Diecke S; Jung SM; Lee J; Ju JH
    Korean J Intern Med; 2014 Sep; 29(5):547-57. PubMed ID: 25228828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic Factors Secreted by Induced Pluripotent Stem Cell-Derived Retinal Progenitors Promote Retinal Survival and Preservation in an Adult Porcine Neuroretina Model.
    Rettinger CL; Kaini RR; Burke TA; Wang HC
    J Ocul Pharmacol Ther; 2021 Jun; 37(5):301-312. PubMed ID: 33661042
    [No Abstract]   [Full Text] [Related]  

  • 13. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
    Osakada F
    Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice-Manufactured Human Induced Pluripotent Stem Cell Line.
    Zhu J; Reynolds J; Garcia T; Cifuentes H; Chew S; Zeng X; Lamba DA
    Stem Cells Transl Med; 2018 Feb; 7(2):210-219. PubMed ID: 29266841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing Functional Retina in a Dish: Progress and Promises of Induced Pluripotent Stem Cell-Based Retinal Neuron Differentiation.
    Wong NK; Yip SP; Huang CL
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using induced pluripotent stem cell-derived conditional medium to attenuate the light-induced photodamaged retina of rats.
    Chang HM; Hung KH; Hsu CC; Lin TC; Chen SY
    J Chin Med Assoc; 2015 Mar; 78(3):169-76. PubMed ID: 25557467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise Review: Towards the Clinical Translation of Induced Pluripotent Stem Cell-Derived Blood Cells-Ready for Take-Off.
    Haake K; Ackermann M; Lachmann N
    Stem Cells Transl Med; 2019 Apr; 8(4):332-339. PubMed ID: 30585439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mini Review: Moving iPSC-Derived Retinal Subtypes Forward for Clinical Applications for Retinal Degenerative Diseases.
    Cho C; Duong TT; Mills JA
    Adv Exp Med Biol; 2019; 1185():557-561. PubMed ID: 31884670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a protocol for maintaining viability while shipping organoid-derived retinal tissue.
    Singh RK; Winkler P; Binette F; Glickman RD; Seiler M; Petersen-Jones SM; Nasonkin IO
    J Tissue Eng Regen Med; 2020 Feb; 14(2):388-394. PubMed ID: 31908157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.